Your browser doesn't support javascript.
loading
Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection.
Wisnivesky, Juan P; Stone, Kimberly; Bagiella, Emilia; Doernberg, Molly; Mendu, Damodara Rao; Lin, Jenny J; Kale, Minal.
  • Wisnivesky JP; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. juan.wisnivesky@mountsinai.org.
  • Stone K; Division Pulmonary and Critical Care Medicine, Icahn School of Medicine at Mount Sinai, NY, New York, USA. juan.wisnivesky@mountsinai.org.
  • Bagiella E; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
  • Doernberg M; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Mendu DR; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
  • Lin JJ; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kale M; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
J Gen Intern Med ; 36(10): 3289-3291, 2021 10.
Article en En | MEDLINE | ID: mdl-34346008

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article